MONDELLO, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 4.026
EU - Europa 3.507
AS - Asia 774
OC - Oceania 7
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 1
Totale 8.324
Nazione #
US - Stati Uniti d'America 4.011
IE - Irlanda 1.157
RU - Federazione Russa 702
SE - Svezia 688
CN - Cina 643
IT - Italia 306
FI - Finlandia 174
PL - Polonia 126
GB - Regno Unito 112
UA - Ucraina 83
DE - Germania 71
IN - India 39
VN - Vietnam 30
BE - Belgio 22
IR - Iran 21
FR - Francia 20
CA - Canada 13
NL - Olanda 13
AT - Austria 10
RO - Romania 8
SG - Singapore 8
KR - Corea 7
AU - Australia 6
JP - Giappone 6
EG - Egitto 5
DK - Danimarca 4
QA - Qatar 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
EU - Europa 3
HU - Ungheria 3
IQ - Iraq 3
SK - Slovacchia (Repubblica Slovacca) 3
ES - Italia 2
LK - Sri Lanka 2
MX - Messico 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
GE - Georgia 1
ID - Indonesia 1
IL - Israele 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 8.324
Città #
Dublin 1.154
Chandler 790
Moscow 690
Nyköping 379
Jacksonville 324
Beijing 249
Princeton 243
Medford 219
Dearborn 184
Des Moines 184
Cambridge 175
Ashburn 174
Messina 137
Warsaw 126
Boardman 91
Ann Arbor 89
Wilmington 88
New York 86
Houston 62
Lancaster 57
San Mateo 55
Shenyang 55
Jinan 50
Nanjing 36
Woodbridge 36
Seattle 35
Dong Ket 28
Haikou 28
Tianjin 28
Hebei 23
Taizhou 23
Zhengzhou 23
Pune 22
Brussels 20
Ningbo 17
Rome 16
Nanchang 15
Falls Church 14
Hyderabad 14
Norwalk 14
Hangzhou 13
Jiaxing 13
Washington 12
Vienna 10
Changsha 9
Fuzhou 9
Lappeenranta 9
Los Angeles 9
Lanzhou 8
Bremen 7
Milan 7
Singapore 7
Tappahannock 7
Catania 6
Hefei 6
London 6
Ottawa 6
Taiyuan 6
Miami 5
Redwood City 5
Arlington 4
Auburn Hills 4
Doha 4
Gainesville 4
Helsinki 4
Paris 4
Phoenix 4
San Francisco 4
Tehran 4
Tokyo 4
Abu Dhabi 3
Cairo 3
Nuremberg 3
Piazza Armerina 3
Riva 3
Allschwil 2
Ampara 2
Ardabil 2
Augusta 2
Bucharest 2
Budapest 2
Canberra 2
Castlebar 2
Castrolibero 2
Fairfield 2
Ferrara 2
Fiumefreddo di Sicilia 2
Giovinazzo 2
Guadalupe 2
Guangzhou 2
Karachi 2
Karaj 2
Kunming 2
Leawood 2
Melbourne 2
Milzano 2
Mineo 2
Montopoli in Val d'Arno 2
Mosciano Sant'Angelo 2
Niscemi 2
Totale 6.318
Nome #
Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury 707
Accuracy of Cystosonography without Voiding Phase in the Diagnosis of Vesicoureteral Reflux in Children: A Variant of the Original Technique 92
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 91
Emerging markers of cachexia predict survival in cancer patients. 88
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 83
Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions. 81
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 81
Autoantibodies in traumatic brain injury and central nervous system trauma. 77
Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients 77
Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. 75
Data comparison between pharmacological induction of labour and spontaneous delivery. A single centre experience 74
Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury 72
A Direct Cortico-Nigral Pathway as Revealed by Constrained Spherical Deconvolution Tractography in Humans 70
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 65
Nodal Ratio as a Prognostic Factor in Patients with Four or More Positive Axillary Nodes Treated with Breast-conserving Therapy and Regional Nodal Irradiation 65
Ubiquitin C-Terminal Hydrolase (UCH-L1): Correlations Exist Between Biofluid Kinetics and Clinical Outcome In Severe Traumatic Brain Injury Patients 63
p-CREB expression in human gliomas: potential use in the differential diagnosis between astrocytoma and oligodendroglioma. 62
Quantitative pupillometry and neuron-specific enolase independently predict return of spontaneous circulation following cardiogenic out-of-hospital cardiac arrest: a prospective pilot study 62
Glutamine-supplemented total parenteral nutrition improves immunological status in anorectic patients 61
Glutamine treatment attenuates the development of ischaemia/reperfusion injury of the gut. 60
alphaII-Spectrin Breakdown Products (SBDPs): Diagnosis and Outcome in Severe Traumatic Brain Injury Patients 59
Bioinformatics approach to understanding interacting pathways in neuropsychiatric disorders. 58
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 58
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 58
Complications of trauma patients admitted to the ICU in level i academic trauma centers in the United States 57
Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial 57
Renal complications in oncohematologic patients. 56
Perceived Stress in a Gender Perspective: A Survey in a Population of Unemployed Subjects of Southern Italy 56
H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol 55
Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice 55
Hypophosphatemia as unusual cause of ARDS in Cushing's syndrome secondary to ectopic CRH production. A case report 54
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 54
Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model 53
Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessment 53
Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options 53
EFFETTI DEL LAVORO A TURNI E NOTTURNO SU LIVELLI COGNITIVI E STATI DELL’UMORE NEI MEDICI IN FORMAZIONE SPECIALISTICA: DATI PRELIMINARI 53
High-Dose Robotic Stereotactic Body Radiotherapy in the Treatment of Patients With Prostate Cancer: Preliminary Results in 26 Patients 52
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 52
Approach to Modeling, Therapy Evaluation, Drug Selection, and Biomarker Assessments for a Multicenter Pre-Clinical Drug Screening Consortium for Acute Therapies in Severe Traumatic Brain Injury: Operation Brain Trauma Therapy 52
Five insights from the Global Burden of Disease Study 2019 51
Nicotinamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy 51
Anesthetic techniques and cancer recurrence after surgery. 51
Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 50
Lymphocytic vasculitis associated with icodextrin. 50
Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literature. 50
Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats 50
Psoriasis and cardiovascular risk: correlation between psoriasis and cardiovascular functional indices 50
Biokinetic Analysis of Ubiquitin C-Terminal Hydrolase-L1 (UCH-L1) in Severe Traumatic Brain Injury Patient Biofluids 50
Biomarkers 49
Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients 49
Elevated Levels of Serum Glial Fibrillary Acidic Protein Breakdown Products in Mild and Moderate Traumatic Brain Injury Are Associated With Intracranial Lesions and Neurosurgical Intervention. 48
Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2 48
Blood-based Diagnostics of Traumatic Brain Injury 47
Quantitative cerebrospinal fluid biokinetic parameters of alpha II-spectrin breakdown products in severe traumatic brain injury patients 47
Acute diagnostic biomarkers for spinal cord injury: review of the literature and preliminary research report 47
Fast Magnetic Resonance Enterography Protocol for the Evaluation of Patients with Crohn's Disease: A Pilot Study 47
Ubiquitin Carboxy-Terminal Hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure 46
CSF and Plasma Amyloid-b Temporal Profiles and Relationships with Neurological Status and Mortality after Severe Traumatic Brain Injury: Results of a Pilot Study 46
Angiotensin receptor antagonists: a potential neuroprotective strategy after brain trauma*. 46
Method to Detect, Monitor and Promote Neural Regeneration and Improvement of Cognitive Function in a Subject Suffering from Neural Injury 46
Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats 45
UCH-L1 levels in CSF and Serum: Diagnosis and Outcome in Severe Traumatic Brain Injury Patients 45
Genotoxic effects of anesthetic agents: an update. 45
Assessing Neuro-Systemic & Behavioral Components in the Pathophysiology of Blast-Related Brain Injury. 45
Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research 45
Changes in Brain Biomarkers and Brain Tissue Oxygenation Following Severe Head Injury: A Case Series 44
Preoperative-Induced Mild Hypothermia Attenuates Neuronal Damage in a Rat Subdural Hematoma Model 44
CSF protein biomarker panel for assessment of neurotoxicity. 44
Night shift work in resident physicians: does it affect mood states and cognitive levels? 44
null 43
ECR 2018 - BOOK OF ABSTRACTS 43
New astroglial injury-defined biomarkers for neurotrauma assessment 43
Development of A TBI Diagnostic Assay System For Multiple Levels Of Care 42
Translating biomarkers research to clinical care: applications and issues for rehabilomics. 42
The hypothalamic-neurohypophyseal system: current and future treatment of vasopressin and oxytocyn related disorders. 42
The Challenge of Mild Traumatic Brain Injury: Role of Biochemical Markers in Diagnosis of Brain Damage. 41
Imaging as a biomarker in drug discovery for Alzheimer's disease: Is MRI a suitable technology? 41
Alpha-synuclein Levels in the Cerebrospinal Fluid of Patients with Parkinson’s Disease and Atypical Parkinsonian Disorders 39
Systems Biology, Bioinformatics, and Biomarkers in Neuropsychiatry 39
Biofluid proteomics and biomarkers in traumatic brain injury 39
Toward Improved Prediction of Outcome In Traumatic Brain Injury: Comparison Between Computed Tomographic Classifications And The Serum Biomarker UCH-L1 38
ASSESSING A NECROSIS AND APOPTOSIS INDEX USING CSF alpha II-SPECTRIN BREAKDOWN PRODUCT LEVELS IN SEVERE TBI 38
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD) 38
Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI 38
Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: a comparison with n-acetylcysteine. 38
Family, lifestyles and new and old type of smoking in young adults: insights from an italian multiple-center study 38
Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. 37
Brain Biomarkers and Brain Tissue Oxygenation: Changes and Correlations Following Severe Head Injury 37
Biokinetic Analysis of Ubiquitin C-terminal Hydrolase (uch-l1) In Severe Traumatic Brain Injury Patient Biofluids 36
A simulated fast magnetic resonance enterography protocol in patients with Crohn's disease: a retrospective, randomized, double-blind study. 36
Microvascular imaging ultrasound (MicroV) and power Doppler vascularization analysis in a pediatric population with early scrotal pain onset 36
CLINICAL UTILITY OF SERUM LEVELS OF UBIQUITIN C-TERMINAL HYDROLASE AS A BIOMARKER FOR SEVERE TRAUMATIC BRAIN INJURY. 35
Novel biomarker signatures for idiopathic REM sleep behavior disorder: A proteomic and system biology approach 35
Rodent models of methamphetamine misuse: Mechanisms of methamphetamine action and comparison of different rodent paradigms 35
Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk 35
Epidemiology and clinical characteristics of traumatic brain injury in Lebanon A systematic review 35
PREDICTING POOR 6-MONTH OUTCOME IN SEVERE TBI USING THE IMPACT SCORE AND EARLY CSF BIOMARKERS. 34
Cyclosporine Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy 34
Levetiracetam Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy 34
Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity 34
Totale 5.746
Categoria #
all - tutte 38.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/2020769 30 12 3 23 6 174 107 82 25 133 156 18
2020/20211.214 60 18 274 45 184 51 18 165 103 173 59 64
2021/20221.224 7 92 18 60 42 15 64 61 18 119 181 547
2022/20233.097 293 194 132 238 207 295 16 162 1.423 21 83 33
2023/20241.515 64 183 56 70 86 194 29 44 8 142 486 153
Totale 8.898